semaglutide patent expiration date semaglutide patent expiry India's weight-loss drugs to get cheaper as expires 50+ Branded Semaglutide Generics To

A new MDL has been created for GLP-1 drug vision loss claims related to Ozempic and similar medications

The makers of Ozempic and Mounjaro, drugs used for both weight loss and diabetes management, are facing a lawsuit claiming the medications can cause "stomach paralysis." Janet Shamlian reports.

at NSF- or USP-certified, cGMP-compliant facilities

The pharmaceutical manufacturers of semaglutide and tirzepatide initiated litigation to stop the production of compounded versions of these medications, and those lawsuits were recently dismissed

has payment of honoraria from Amgen, Boehringer Ingelheim, Bruno Farmaceutici, Eli-Lilly, Novo Nordisk, Pfizer, Recordati, Regeneron and Roche

New research published in the Foundations journal Crohns & Colitis 360 found that people with IBD who use GLP-1 medicationscommonly prescribed for diabetes and obesityhad a lower risk of major heart-related complications